Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04387136 · ClinicalTrials.gov registry record · Phase 4
Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT04387136 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 53 participants.
The verdict
NCT04387136, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.
Interventions
- DRUG Sublingual Sufentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2021-02-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04387136
The ClinicalTrials.gov registry entry for NCT04387136 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sublingual Sufentanil is the first listed.
NCT04387136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04387136 about?
NCT04387136 is a clinical study titled "Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center". The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.
What is the current status of trial NCT04387136?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2020-10-14. Estimated completion is 2021-02-04.
What interventions are being tested in trial NCT04387136?
The interventions under investigation include: Sublingual Sufentanil (DRUG).
Who is sponsoring clinical trial NCT04387136?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.